Head of New York Life Ventures, Joel Albarella, appeared on a recent episode of New York Life Investment’s Market Matters podcast alongside hosts Lauren Goodwin and Robert Serenbetz. The conversation focused on New York Life Ventures’ work accelerating the pace of innovation at New York Life as the company’s corporate venture capital arm, and Joel’s perspectives on the current state of the venture capital landscape and how companies are adapting in response to the COVID-19 pandemic.
Topics discussed included how:
- New York Life Ventures employs an “investing and testing” approach in working to deliver both investment returns and strategic value to New York Life, while also providing significant value to start-up partners as well.
- Being one of the first life insurance corporate venture capital teams, even predating the concept of Insurtech, enabled New York Life Ventures to be creative when exploring technologies and searching for value.
- Trusted relationships are critical to building sustainable bridges between New York Life and the start-up community to address the deeply embedded demand for new technologies.
- The ever-growing corporate venture capital segment within the overall venture capital space continues to grow and was involved in about ¼ of all deals in 2019* .
- New York Life, as a mutual life insurance company with 175 years of experience with long term orientation operating solely in the best interests of the company’s policy owners, presents an ideal and fertile environment for venture capital investing and testing new technologies.
Listen to the full episode here .
*Source (NVCA & Pitchbook) https://nvca.org/wp-content/uploads/2020/03/NVCA-2020-Yearbook.pdf
Go back to our newsroom to read more stories.